The nefgene product encoded by the mac239 proviral done of simian immunodeficiency virus (SIV) markedly enhances viral replication and pathogenesis in vivo. We have used this biologicaUy active nefisolate to examine the phenotype of Nef in retrovirally transduced human T cells in culture. SIV Nefis shown to dramatically inhibit cell-surface expression of the CD4 glycoprorein without significantly affecting the total steady-state level of cellular CD4. This downregulation of the cell-surface CD4 receptor for human immunodeficiency virus type 1 (HIV-1) infection correlated with the acquisition of resistance to superinfection by HIV-1. However, SIV Nef did not affect the level of gene expression directed by the HIV-1 long terminal repeat. It is hypothesized that downregulation of cell-surface CD4 by Nef facilitates the efficient release of infectious progeny virions and, hence, viral spread in vivo.
T
he Nef protein of HIV-1 is an NH2-terminally myristoylated protein of '~27 kD that associates with the cytoplasmic membranes of expressing calls (1) (2) (3) . Nefis expressed early in the viral replication cycle from a set of multiply spliced mRNA species that also encodes the viral regulatory proteins Tat and Rev (4, 5) . Unlike Tat and Rev, which are essential for viral replication in culture (4), the Nef gene product is clearly dispensable, although investigators differ on whether Nef has a slight inhibitory effect (6) (7) (8) , no detectable phenotype (3, 9, 10) , or a slight positive effect (11, 12) on the rate of replication. The difficulty of establishing a clear phenotype for HIV-1 Nef in culture, and of identifying fully active copies of nef, has been compounded by the high variability of the Nef open reading frame between different viral isolates (13, 14) .
Recently, Kestler et al. (15) demonstrated that Nef is essential for both viral replication and pathogenesis in rhesus macaques infected with the mac239 proviral clone of simian immunodeficiency virus (SIV), 1 an animal model for HIV-1 infection that accurately reproduces much of the pathology seen in humans. This study both emphasized the critical importance of this protein in the viral life cycle and also identified, for the first time, a cloned nefgene that clearly retained full 1 Abbreviations used in this paper: cat, chloroamphenicol acetyl transferase; CMV-IE, cytomegalovirus immediate early; SIV, simian immunodeficiency virus.
biological activity. Here, we demonstrate that stable expression of this SIV Nef protein in human CD4 + T cells results in the downregulation of cell-surface CD4 expression and renders these cells resistant to infection by HIV-1.
Materials and Methods
Construction and Use of Retroviral Vectors. The nefgene was isolated from the SIVm~239 proviral done (15) by the PCR (16) using primers that introduced unique EcoRI (5') and Xhol (3') restriction enzyme sites. The nef gene was then inserted into the polylinker present in the LXSN retroviral expression vector (17) where it would be transcribed under the control of the viral LTR promoter. Similar constructs containing the prokaryotic chloramphenicol acetyl transferase (cat) gene (18) or the mutant M10 form of the HIV-1 rev gene (19) were also prepared. The resultant plasmids were transfected into the packaging cell line GP+ ENV-AM12 (20) , and the released amphotropic retroviral particles used to infect the human CD4 + T ceil line CEM-SS (21) . Infected CEM-SS cells were selected on the basis of acquisition of resistance to G418 and maintained as a pool (CEM-NEFP) or subjected to single-ceil doning by end-point dilution (all other cell lines).
Immunological (23) . After cell lysis, radiolabeled proteins were subjected to immunoprecipitation (23) using an antiserum obtained from an SIV-infected rhesus macaque (15) . Precipitated proteins were resolved by electrophoresis through a 10% SDS-acrylamide gel and visualized by autoradiography.
The level of expression of CD4 in the various transduced CEM-SS T cell lines was quantitated by Western blot analysis. Cells (107) derived from the CEM-SS subclones and from the cell lines HeLa and HeLa/CD4 clone 1022 (24) were lysed in 1 ml of TNE (50 mM Tris-HC1, pH 8.0, 1% NP-40, 2 mM EDTA, 100 #M Na3VO4, 20 tzg/ml leupeptin) and immunoprecipitated overnight (23) at 4~ with 200 #1 of OKT4 prebound to 10% protein A-Sepharose (Pharmacia Inc., Piscataway, NJ). The beads were extensively washed before adherent proteins were solubilized by heating at 100~ in Laemmli sample buffer. Precipitated proteins were separated by electrophoresis through an 8% SDS-polyacrylamide gel before transfer to nitrocellulose (Scheicher & Schuell, Inc., Keene, NH). The membrane was preincubated in 10 mM Tris-HC1, pH 8.0, 150 mM NaC1, 0.5% Tween 20, 5% nonfat milk, and then hybridized overnight at room temperature using a 1:1000 dilution of a rabbit anti-CD4 polyclonal antibody (22) . Anti-CD4 antibody binding was visualized using a goat anti-rabbit antiserum conjugated to alkaline phosphatase (GIBCO-BRL, Gaithersburg, MD). The quantitative recovery of the ,,o55-kD CD4 protein was confirmed by the demonstration that immunoprecipitation of the supernatant for a second time brought down minor and equal amounts of CD4 for all the CEM-SS cell lines tested.
Cell Culture and Viral Infection. All CEM-SS ceil lines were maintained in RPMI-1640 medium supplemented with 10% FCS and gentamycin. Transduced cells were selected and maintained in 0.8 mg/ml G418. Viral replication was analyzed by infecting cells (5 x 10 s) derived from each of the various CEM-SS subdones with 0.5 ml of a viral stock of the HIV-1 isolate IIIB (19) . Titration by end-point dilution demonstrated that this stock contained ~4 x 103 median tissue culture infectious doses per ml for CEM-SS cells. At 3 d after infection, the cells were pelleted, washed, and resuspended at 106 cells per ml in fresh medium. This process was repeated at 2-d intervals in conjunction with sampling of the media for analysis of viral replication rate. The level of p24 Gag secreted into the supernatant media over each 48-h period was determined using a quantitative ELISA (DuPont Biotechnology, Wilmington, DE).
Transfection Assays. Cells (2 x 106) derived from the CEM-SS subclones were transfected (19) using plasmids (4 #g) containing the cat gene under the control of the HIV-1 LTK promoter (BC12/HIV/CAT) or the cytomegalovirus immediate early (CMV-IE) promoter (BC12/CMV/CAT) (25) . The HIV/CAT phsmid was cotransfected with 2 #g of a plasmid (pcTat) encoding the HIV-1
Tat trans-activator while the CMV/CAT plasmid was cotransfected with an equal level of a negative control plasmid (pBC12/CMV) (25) . At 48 h after transfection, the cultures were harvested, and relative levels of CAT enzyme activity, in counts per minute, determined by the diffusion method (18) . The presented values were adjusted for minor variability in the level of total protein in each extract, as determined by the method of Bradford (26) . 
Results
To examine the properties of the SlVmar nef gene product in culture, we stably transduced the HIV-1 permissive human CD4 + T cell line CEM-SS (21) with amphotropic retroviral vectors designed to express either Nef, the prokaryotic cat gene or the trans-dominant negative M10 mutant of HIV-1 Key. (19) (Fig. 1) . Transduced cells were maintained either as heterogeneous pools (CEM-NEFP) or as homogeneous subdones (CEM-NEF1, 4, 6, and 8; CEM-M10; CEM-CAT and -CAT2). Immunoprecipitation analysis using antiserum derived from an SIV-infected macaque (15) confirmed expression of the ,v34-kD SIV Nef protein in CEM-SS cells transduced with the retroviral Nef expression construct (Fig. 1, lanes 4-8) .
Although it has been argued that expression of HIV-1 nef results in a significant downregulation of cell-surface CD4 expression (27) , others have been unable to reproduce this effect (7, 8, 10) . We examined the effect of SIV Nef on the cell-surface expression of CD4 and other antigens using flow cytometric analysis (Fig. 2 A) . Expression of cell-surface CD4 was uniformly high (>~94% positive) on the Nef-T cells (Fig. 2 B) . In contrast, Nef-expressing T cells displayed low levels of CD4 positivity ranging from a high of *28% in the undoned CEM-NEFP cells to a low of'~3% in the CEM-NEF1 subclone. This reduction proved stable over several months in culture and was not due to a conformational change in the CD4 epitope or masking, as essentially identical data were obtained with a range of anti-CD4 mAbs (Leu3A, OKT4, OKT4B, OKT4C, and OKT4D) specific for different CD4 epitopes, as well as with a rabbit polyclonal anti-CD4 antiserum (22) . This effect was also specific, in that no significant reduction in the cell-surface expression of HLA-ABC, HLA-DR, TCR, intercellular adhesion molecule 1 (ICAM-1), CD38, CD45, or CD69 was observed ( Fig. 2 B and data not shown). Quantitative flow cytometric analysis of the CEM-SS subdones CEM-NEF1 and CEM-CAT confirmed a 97% reduction in the average number of cell-surface CD4 molecules on the surface of these Nef-expressing T cells (Fig. 2 A) . Of interest, the two subclones that displayed the greatest reduction in cell-surface CD4 expression, i.e., CEM-NEF1 and CEM-NEF8, also expressed the highest level of Nef (Fig. 1, lanes 5 and 8) .
To identify the level at which Nef affected cell-surface expression of CD4, we next measured the steady-state level of CD4 protein expression using Western blot analysis (Fig. 3) . These data revealed that the level of expression of CD4 in the Nef + T cells was unchanged relative to that observed in the Nef-cells. Immunoprecipitation analysis of pulselabeled cells demonstrated that the rate of CD4 protein synthesis was also unaffected by coexpression of Nef (data not shown). We therefore conclude that dowuregnlation of cellsurface CD4 expression by Nef results from the sequestration of CD4 in a currently unidentified intracellular compartment. However, the observation that the relative mobility of the CD4 glycoprotein in the CEM-Nef cells was indistinguishable from that observed in the parental CEM-SS cells suggests that Nef does not affect the normal posttranslation processing of CD4.
The CD4 molecule is the cell-surface receptor for both HIV-1 and SIV (4). Inhibition of cell-surface CD4 expression might therefore be predicted to reduce the efficiency of viral infection of T cells in culture. To test this possibility, we infected CEM-SS cells, three transduced Nef-cell lines (CEM-CAT, -CAT2, and -M10) and five Nef + cell lines (NEFP, 1, 4, 6, and 8) with a constant level of the HIV-1 isolate IIIB. The rate of spread of the virus was then monitored by measurement of supernatant p24 Gag protein. As shown in Fig. 4 , both the parental CEM-SS T cells and the two subclones transduced with the cat gene were highly permissive for HIV-1 replication. The cell line CEM-M10 expresses the tram-dominant negative M10 mutant of HIV-1 Rev previously shown to confer significant resistance to HIV-1 replication in culture (19) . The data presented in Fig. 4 Days Post-Infection (HIWCAT) or under the control of a human cytomegalovirus promoter (CMWCAT) (25) . In the former case, we also cotransfected an expression vector encoding the HIV-1 Tat trans-activator (25) . If Nef were a specific inhibitor of LTR-specific gene expression, we would predict that the level of CAT expression induced by the HIWCAT vector would be markedly reduced in cells that express Nef, when compared to the level seen with the CMWCAT plasmid. However, these studies failed to demonstrate any inhibitory effect of SIV Nef on HIV-l-specific gene expression (Table 1 ). These observations are therefore consistent with earlier reports that have failed to detect an inhibitory effect of either SIV Nef or HIV-1 Nefon viral gene expression in culture (3, 9, 10, 15) .
Discussion
The nefgene of the mac239 proviral done of SIV is unique in that the full biological activity of the encoded protein has been validated in vivo (15) . In this report, we have used human CD4 + T cells transduced with a retroviral nef expression vector to examine the in vitro properties of this viral gene product. We demonstrate that expression of SIV Nef dramatically and specifically reduces call-surface expression of the CD4 glycoprotein receptor but has no detectable effect on the steady-state level of CD4 protein expression. These observations therefore serve to validate the similar, yet controversial (7, 8, 10) , data of Garcia and Miller (27) obtained using the nef gene of HIV-1 strain SF2. Most importantly, of the four Nef-expressing CEM-SS subdones demonstrated an even more dramatic inhibition in the rate of viral replication, although a low level of virion production did remain detectable throughout the experimental time course. The pool of G418-resistant T cells (CEM-NEFP) obtained after the initial infection of CEM-SS cells with the retroviral Nef expression vector proved somewhat more permissive for the spread of HIV-1 (Fig. 4) . We hypothesize that this intermediate phenotype reflects the heterogeneous nature, in terms of proviral integration site and Nef expression, of this transduced T cell population when compared with the Nef-expressing subclones, a hypothesis also consistent with the broad range of cell-surface CD4 expression observed on these cells by flow cytometry (data not shown).
The data presented in Fig. 4 demonstrate that expression of Nef can render T cells resistant to HIV-1 infection. As Nef expression inhibits cell-surface expression of CD4, it seemed likely that this resistance resulted from a block to viral penetration. Previous studies demonstrating that cultures displaying low levels of cell-surface CD4 are less susceptible to infection by HIV-1 are consistent with this interpretation (28) . However, it has also been proposed that Nef might inhibit transcription directed by the HIV-1 LTR (29, 30) . To test whether the inhibition of HIV-1 replication in these Nef-expressing CEM-SS cells resulted from an inhibition of HIV-1 LTR-specific gene expression, we transfected Nef-expressing and control T cells with plasmids containing the cat indicator gene under the control of the HIV-1 LTR LTR or the CMV-IE promoter (25) . In the former case, a plasmid that directs expression of the HIV-1 Tat trans-activator was also cotransfected. A comparison of the level of CAT enzyme activity (18) induced by the HIV-1 LTR construct with that induced by the CMV promoter construct demonstrates that these promoters give comparable levels of enzyme activity in transfected cells regardless of Nef expression. These data are representative of three independent experiments and have been corrected for the low level of background activity (364 cpm) observed in mock-transfected CEM-SS cells.
T cells expressing Nef are shown to be highly resistant to HIV-1 infection, yet retain the ability to support effident transcription from the HIV-1 LTR promoter. We therefore hypothesize that the downregulation of cell-surface CD4 has rendered these cells, in effect, resistant to superinfection by SIV or HIV-1. If downregulation of surface CD4, and the associated inhibition of superinfection, represents the only function of Nef, then why does this enhance virus spread in vivo? It does not appear probable that inhibition of superinfection by exogenous virions is likely to provide a major selective advantage, as the virus load in vivo is low compared with the number of available CD4 + target cells (15) . We hypothesize, instead, that downregulation of CD4 is designed to facilitate the efficient release of infectious progeny virions from the infected cell by preventing the sequestration of viral envelope (Env) protein or by preventing continuous CD4-mediated reinfection.
Several groups have demonstrated that CD4 and HIV-1 Env can functionally interact in the endoplasmic reticulum (EK) (31) (32) (33) . This process can lead to the retention of both proteins within the ER and hence to their functional inactivation (31) (32) (33) . Extensive superinfection of cultured human T cells by HIV-1 has also been reported (34, 35) . Whereas such superinfection results in the accumulation of large amounts ofproviral DNA, it does not augment virus production and, therefore, presumably inhibits virus spread (34, 35) . Particularly relevant is the recent demonstration by Marshall et al. (36) that high level expression of cell-surface CD4 can effectively block the cell-to-cell transmission of HIV-1 in culture, but does not inhibit infection by exogenously added virus. These authors suggest that this inhibition of virus spread results from the inability of progeny virions to effectively disengage from infected cells that express high levels of cellsurface CD4. Conditions that reduce the ability of released virions to diffuse away from an infected T cell that continues to express surface CD4 would therefore be predicted to maximize the positive effect of Nef on the rate of spread of HIV-1. We hypothesize that such conditions might well include the far greater cell density that exists, for example, in an HIV-1-infected lymph node in vivo when compared with an in vitro T cell culture. Precedent for a viral protein that functions to enhance viral release and spread by removal of receptors from the surface of infected cells exists in the form of influenza virus neuraminidase, which has been shown to destroy such receptors by removal of terminal sialic acid residues (37) . These considerations suggest that demonstration of a positive effect of Nef on HIV-1 replication in vitro should be achievable by appropriate modification of cell culture conditions, as has already been demonstrated by some groups (11, 12) .
